康泰生物：杜兴连计划减持公司股份不超过约272万股

Group 1 - The core point of the news is that Kangtai Biological (SZ 300601) announced a share reduction plan by its major shareholder, which will not affect the company's governance structure or control [1] - The major shareholder, Ms. Du Xinglian, plans to reduce her holdings by up to approximately 2.72 million shares, representing 0.24% of the total share capital, within three months after the announcement [1] - For the year 2024, Kangtai Biological's revenue composition is projected to be 98.31% from biological products and 1.69% from other business income [1] Group 2 - As of the report, Kangtai Biological has a market capitalization of 19.5 billion yuan [2]